Investigation of Potential Anticarcinogenic Effects of Corilagin in Lung Cancer Cells
- 30 September 2019
- journal article
- research article
- Published by Marmara University in Clinical and Experimental Health Sciences
- Vol. 9 (3) , 228-231
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Corilagin inhibits hepatocellular carcinoma cell proliferation by inducing G2/M phase arrestCell Biology International, 2013
- A potential anti-tumor herbal medicine, Corilagin, inhibits ovarian cancer cell growth through blocking the TGF-β signaling pathwaysBMC Complementary and Alternative Medicine, 2013
- Isolation and characterization of ellagitannins as the major polyphenolic components of Longan (Dimocarpus longan Lour) seedsPhytochemistry, 2012
- Classification of Lung CancerSeminars in Roentgenology, 2011
- In vivo anti-tumour activity of corilagin on Hep3B hepatocellular carcinomaPhytomedicine, 2010
- Phyllanthus urinaria extract attenuates acetaminophen induced hepatotoxicity: Involvement of cytochrome P450 CYP2E1Phytomedicine, 2009
- Antioxidant and hepatoprotective actions of medicinal herb, Terminalia catappa L. from Okinawa Island and its tannin corilaginPhytomedicine, 2007
- Twenty-five years of treating advanced NSCLC: what have we achieved?Annals of Oncology, 2004
- Modulation of PAI-1 and tPA Activity and Thrombolytic Effects of CorilaginPlanta Medica, 2003
- Antihypertensive effect of corilagin in the ratCanadian Journal of Physiology and Pharmacology, 1995